EUVIMEDEUVIMED entdecken
Crossref

Avascular necrosis in sickle cell disease needs more definitive treatment options

Najibah A Galadanci, Julie Kanter iD

British Journal of Haematology · 2025

DOI: 10.1111/bjh.19879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Najibah A Galadanci und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabam…. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Osteonecrosis. Die Arbeit nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Avascular necrosis (AVN) is a bone disease caused by a temporary or definitive loss of the blood supply to bone resulting in cellular death. In people with sickle cell disease (SCD), AVN is one of the most common causes of severe chronic pain. Currently, there are very few treatment options for AVN and the current study by Casale et al. demonstrates how the use of patient‐reported outcomes can bring us one step closer to identifying optimal treatments for this debilitating condition in SCD. Commentary on: Casale et al. Long‐term outcomes of Avascular Necrosis in Sickle Cell Disease using joint‐specific patient‐reported outcome measures: Results from a multicentre study. Br J Haematol 2025; 206:310‐319.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellOsteonecrosisHumansMaleFemalePatient Reported Outcome Measures

Stichwörter der Autor:innen

avascular necrosisbone diseasesickle cell disease

Autor:innen und Institutionen

  • Division of Hematology and Oncology, Department of Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA.

ORCID-Profile: Julie Kanter

Zitieren

APA

Galadanci, N. A., & Kanter, J. (2025). Avascular necrosis in sickle cell disease needs more definitive treatment options. British Journal of Haematology. https://doi.org/10.1111/bjh.19879

Vancouver

Galadanci NA, Kanter J. Avascular necrosis in sickle cell disease needs more definitive treatment options. British Journal of Haematology. 2025. doi:10.1111/bjh.19879

BibTeX
@article{Galadanci2025,
  author = {Galadanci, Najibah A and Kanter, Julie},
  title = {Avascular necrosis in sickle cell disease needs more definitive treatment options},
  journal = {British Journal of Haematology},
  year = {2025},
  doi = {10.1111/bjh.19879}
}
Kostenlos starten →